|
Madeleine, Margaret M; Anttila, Tarja; Schwartz, Stephen M et al. (2007) Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer 120:650-5
|
|
Andersen, M Robyn; Schroeder, Tom; Gaul, Marcia et al. (2005) Using a population-based cancer registry for recruitment of newly diagnosed patients with ovarian cancer. Am J Clin Oncol 28:17-20
|
|
Doherty, Jennifer A; Weiss, Noel S; Freeman, Robert J et al. (2005) Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 14:357-66
|
|
Friedrichsen, Danielle M; Malone, Kathleen E; Doody, David R et al. (2004) Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young women. Breast Cancer Res 6:R629-35
|
|
Suter, Nicola M; Malone, Kathleen E; Daling, Janet R et al. (2003) Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women. Cancer Epidemiol Biomarkers Prev 12:127-35
|
|
Littman, Alyson J; Rossing, Mary Anne; Madeleine, Margaret M et al. (2003) Association between late age at infectious mononucleosis, Epstein-Barr virus antibodies, and ovarian cancer risk. Scand J Infect Dis 35:728-35
|
|
Potosky, Arnold L; Reeve, Bryce B; Clegg, Limin X et al. (2002) Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst 94:430-7
|
|
Custer, Brian S; Koepsell, Thomas D; Mueller, Beth A (2002) The association between breast carcinoma and meningioma in women. Cancer 94:1626-35
|
|
Newcomer, L M; King, I B; Wicklund, K G et al. (2001) The association of fatty acids with prostate cancer risk. Prostate 47:262-8
|
|
Potosky, A L; Knopf, K; Clegg, L X et al. (2001) Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study. J Clin Oncol 19:3750-7
|
Showing the most recent 10 out of 14 publications
